Cellebrite DI (CLBT) Cost of Revenue (2020 - 2025)

Cellebrite DI (CLBT) has reported Cost of Revenue for 6 consecutive years, with $38.6 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cost of Revenue rose 8.55% year-over-year to $38.6 million; the TTM figure through Dec 2025 stood at $154.8 million (up 16.94% YoY), while the FY2025 annual figure was $154.8 million, up 147.33% from the prior year.
• Cost of Revenue came in at $38.6 million for Q4 2025 at Cellebrite DI, down from $38.8 million in the prior quarter.
• The five-year high for Cost of Revenue was $38.8 million in Q3 2025, with the low at $16.5 million in Q1 2021.
• Average Cost of Revenue over 5 years is $28.6 million, with a median of $27.2 million recorded in 2023.
• Across the five-year window, Cost of Revenue surged 40.81% in 2022 and rose 5.11% in 2023, its largest moves.
• Year by year, Cost of Revenue stood at $21.2 million in 2021, then increased by 11.44% to $23.7 million in 2022, then grew by 25.03% to $29.6 million in 2023, then advanced by 20.04% to $35.5 million in 2024, then climbed by 8.55% to $38.6 million in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $38.6 million, $38.8 million, and $38.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.